M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Long-Term Debt Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Long-Term Debt
$416.3m
CAGR 3-Years
124%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Long-Term Debt
CHf2.5m
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Long-Term Debt
CHf1.8m
CAGR 3-Years
-30%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Long-Term Debt
CHf55.8m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Long-Term Debt?
Long-Term Debt
0 USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Long-Term Debt amounts to 0 USD.

Back to Top